Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-27

Study Completion Date

2025-07-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy

NCT02924532

Hypoparathyroidism

COMPLETED

A Registry for Participants With Chronic Hypoparathyroidism

NCT01922440

Hypoparathyroidism

ACTIVE_NOT_RECRUITING

Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism

NCT00004661

Pseudohypoparathyroidism

COMPLETED

Does Indocyanine Imaging Scoring Predicts Postoperative Parathormone Levels at 24 Hours After Total Thyroidectomy

NCT03910049

Thyroid Parathyroid; Deficiency

COMPLETED

Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities

NCT04671719

Fibrous Dysplasia Albright Syndrome Adult Children +3 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endocrinologists from both sectors (public and private) are participating in the study. Data will be captured electronically by DACIMA Clinical Suite, according to FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPAA (Health Insurance Portability and Accountability Act) \& ICH (International Conference on Harmonisation) requirements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoparathyroidism Pseudo Hypoparathyroidism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hypoparathyroidism defined by low serum calcium \< 2.2 mmol/l (\< 88 mg/l) associated with inadequate PTH (low or normal) and normal creatinine

Exclusion Criteria

* Cervical surgery \< 6 months.
* Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.
* Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.
* Familial hypocalcemia hypercalciuria.
* Pseudo-pseudo-hypoparathyroidism.

Eligible Sex

ALL

Accepts Healthy Volunteers

No